NYSOMH Issues Alerts, Guidelines re Antidepressant Use in Children, Teens Wed, 29 Dec 2004 The NYS Office of Mental Health has issued letters and an advisory to state mental health providers “explaining” FDA’s warning and the use of antidepressants in children. As you will note, OMH downplays the meaning of…
Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions? Wed, 22 Sep 2004 FDA’s complicity in concealing vital drug safety information that might have saved lives, is the subject of tomorrow’s hearing by the House subcommittee on Oversight and Investigations. Rayburn Office Bldg, room 2123 at 11:00….
FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk Fri, 15 Oct 2004 We have won the first battle in a struggle for full disclose of serious adverse drug effects and disclosure of failed clinical trials. Prescribing physicians and the public have…
Can a Popular Antidepressant Cause Teenage Suicide? Boston Globe Wed, 6 Aug 2003 For years, drug manufacturers and regulators (in the UK and US) have falsely maintained that antidepressants–such as Paxil (Seroxat), Prozac, and the other SSRIs–reduce the risk of suicide, and, they maintained, the drugs are not addictive. An…
Evidence of Antidepressant Harm that the FDA Sought to Suppress from FDA’s Public Advisory Committee Meeting on February 2 Evidence was presented on February 2 at AHRP’s press briefing by the following scientists: David Healy, MD, Director of the North Wales Department of Psychological Medicine and Visiting Professor, University of…
European Medicines Agency finalises review of antidepressants in children / adolescents Tue, 26 Apr 2005 The European Medicines Agency (EMA) has issued a press release recommending warnings about the increased risk of suicide attempts and hostility for children and adolescents prescribed an SSRI or SNRI antidepressant –and added warnings about…
Hearing on Antidepressants Canceled – Washington Post Wed, 21 Jul 2004 The Washington Post confirms AHRP’s assessment about the real reason for the derailment of a much awaited congressional hearing at which the giants of the pharmaceutical industry were to testify: “A Democratic staff member who spoke on the condition…
Glaxo chief: “Our drugs do not work on most patients” Mon, 8 Dec 2003 Dr. Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), Britain’s giant pharmaceutical company, acknowledged at a scientific meeting in London that fewer than half of the patients prescribed some of the most expensive drugs actually…
FDA Statement Regarding Anti-Depressant Paxil for Children Thu, 19 Jun 2003 A knowledgeable critic suggested that the FDA was pushed into action, but the action (Statement below) is weak. Evidence about the risks of antidepressants such as Paxil (Seroxat) have been linked to severe withdrawal symptoms which are a sign…
FDA Tones Down Warning–Shyra Kallas an SSRI Suicide Victim Fri, 4 Mar 2005 In his recent testimony before the Senate Health, Education, Labor, and Pensions committee, Dr. David Fassler, representing the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP), misrepresented the scientific facts about…
Intimidation, Politics and Drug Industry Cripple U.S. Medicine – FDA Permits Dr. David Graham to publish Vioxx Report Wed, 5 Jan 2005 FDA officials could not maintain their iron grip in an effort to suppress evidence of far reaching lethal effects of Vioxx when their actions were in full public…
Worldwide Drug Industry Ailing – PhaRMA Giants Reeling Blockbuster Drugs Found Hazardous Sat, 18 Dec 2004 Daily headlines provide confirmatory evidence supporting what critics of the drug industry have been say:ing for years. First, as The New York Times notes in one of its 4 articles about the latest “unexpected”…
